153 related articles for article (PubMed ID: 29178515)
1. Visualization of dendritic cells' responses in atopic dermatitis: Preventing effect of emollient.
Mias C; Le Digabel J; Filiol J; Gontier E; Gravier E; Villaret A; Nocera T; Questel E; Rossi AB; Redoulès D; Josse G
Exp Dermatol; 2018 Apr; 27(4):374-377. PubMed ID: 29178515
[TBL] [Abstract][Full Text] [Related]
2. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis.
Yoshida K; Kubo A; Fujita H; Yokouchi M; Ishii K; Kawasaki H; Nomura T; Shimizu H; Kouyama K; Ebihara T; Nagao K; Amagai M
J Allergy Clin Immunol; 2014 Oct; 134(4):856-64. PubMed ID: 25282566
[TBL] [Abstract][Full Text] [Related]
3. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis.
Kerschenlohr K; Decard S; Przybilla B; Wollenberg A
J Allergy Clin Immunol; 2003 Apr; 111(4):869-74. PubMed ID: 12704371
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
[TBL] [Abstract][Full Text] [Related]
5. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro.
Novak N; Valenta R; Bohle B; Laffer S; Haberstok J; Kraft S; Bieber T
J Allergy Clin Immunol; 2004 May; 113(5):949-57. PubMed ID: 15131579
[TBL] [Abstract][Full Text] [Related]
6. A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence.
Quadri M; Lotti R; Bonzano L; Ciardo S; Guanti MB; Pellacani G; Pincelli C; Marconi A
Skin Pharmacol Physiol; 2021; 34(1):8-18. PubMed ID: 33601378
[TBL] [Abstract][Full Text] [Related]
7. Effect of an Emollient on the Mycobiome of Atopic Dermatitis Patients.
Chandra J; Retuerto M; Seité S; Martin R; Kus M; Ghannoum MA; Baron E; Mukherjee PK
J Drugs Dermatol; 2018 Oct; 17(10):1039-1048. PubMed ID: 30365583
[TBL] [Abstract][Full Text] [Related]
8. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
[TBL] [Abstract][Full Text] [Related]
9. [Langerhans cells in the physiopathology of atopic dermatitis].
Bieber T; Bruijnzeel-Koomen C
Ann Dermatol Venereol; 1990; 117(3):185-93. PubMed ID: 2193589
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
[TBL] [Abstract][Full Text] [Related]
11. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient.
Billmann-Eberwein C; Rippke F; Ruzicka T; Krutmann J
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):100-4. PubMed ID: 11867966
[TBL] [Abstract][Full Text] [Related]
12. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
[TBL] [Abstract][Full Text] [Related]
13. Emollient Acceptability in Childhood Atopic Dermatitis: Not All Emollients are Equal.
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
Curr Pediatr Rev; 2018; 14(2):117-122. PubMed ID: 28578641
[TBL] [Abstract][Full Text] [Related]
14. Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients.
Wollenberg A; Fölster-Holst R; Saint Aroman M; Sampogna F; Vestergaard C
J Eur Acad Dermatol Venereol; 2018 Apr; 32 Suppl 1():1-15. PubMed ID: 29533490
[TBL] [Abstract][Full Text] [Related]
15. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
[TBL] [Abstract][Full Text] [Related]
16. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
Ayala-García I; Hernández-Segura AM; Castell-Rodríguez A; Alvarez Pérez SJ; Téllez BH; Ramírez-González MD
Proc West Pharmacol Soc; 2005; 48():13-20. PubMed ID: 16416652
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants.
McClanahan D; Wong A; Kezic S; Samrao A; Hajar T; Hill E; Simpson EL
J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2087-2094. PubMed ID: 31287580
[TBL] [Abstract][Full Text] [Related]
18. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
Kircik LH
J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
[TBL] [Abstract][Full Text] [Related]
19. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
20. Expression of Co-stimulatory molecules on langerhans cells in lesional epidermis of human atopic dermatitis.
Fesenkova VI; Kurchenko AI; Castellani ML; Conti P; Anogeianaki A; Caraffa A; Kalogeromitros D
Immunopharmacol Immunotoxicol; 2007; 29(3-4):487-98. PubMed ID: 18075860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
